MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with N

Nintedanib

Nintedanib 25mg capsules

No stability information

Stability notes for Nintedanib 25mg capsules

There are no stability notes for this medicine.

Supplier

Ofev 25mg capsules (Boehringer Ingelheim Ltd)

Nintedanib 100mg capsules

No stability information

Stability notes for Nintedanib 100mg capsules

There are no stability notes for this medicine.

Suppliers (7) of Nintedanib 100mg capsules
Nintedanib 100mg capsules (Accord-UK Ltd)
Nintedanib 100mg capsules (Advanz Pharma)
Nintedanib 100mg capsules (Celix Pharma Ltd)
Nintedanib 100mg capsules (Dr Reddy's Laboratories (UK) Ltd)
Nintedanib 100mg capsules (Teva UK Ltd)
Ofev 100mg capsules (Boehringer Ingelheim Ltd)
Vargatef 100mg capsules (Boehringer Ingelheim Ltd)

Nintedanib 150mg capsules

No stability information

Stability notes for Nintedanib 150mg capsules

There are no stability notes for this medicine.

Suppliers (7) of Nintedanib 150mg capsules
Nintedanib 150mg capsules (Accord-UK Ltd)
Nintedanib 150mg capsules (Advanz Pharma)
Nintedanib 150mg capsules (Celix Pharma Ltd)
Nintedanib 150mg capsules (Dr Reddy's Laboratories (UK) Ltd)
Nintedanib 150mg capsules (Teva UK Ltd)
Ofev 150mg capsules (Boehringer Ingelheim Ltd)
Vargatef 150mg capsules (Boehringer Ingelheim Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.